CY1110476T1 - Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατη - Google Patents
Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατηInfo
- Publication number
- CY1110476T1 CY1110476T1 CY20091100622T CY091100622T CY1110476T1 CY 1110476 T1 CY1110476 T1 CY 1110476T1 CY 20091100622 T CY20091100622 T CY 20091100622T CY 091100622 T CY091100622 T CY 091100622T CY 1110476 T1 CY1110476 T1 CY 1110476T1
- Authority
- CY
- Cyprus
- Prior art keywords
- protective
- ramiprilat
- retinal
- ramipril
- field
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η εφεύρεση αφορά ένα νευροπροστατευτικό και αμφιβληστροειδο-προστατευτικό φάρμακο, του οποίου το δραστικό συστατικό επιλέγεται εντός μιας ομάδας ενώσεων που αποτελούνται από την ραμιπρίλη, ραμιπριλάτη ή κάθε άλλο παράγωγο της ραμιπριλάτης ικανό να απελευθερώνεται εντός του οργανισμού στον οποίο χορηγείται. Εφαρμόζεται για την πρόληψη, ή ακόμη τη βελτίωση της οπτικής οξύτητας και του οπτικού πεδίου σε φυσιολογικά άτομα, καθώς και τη θεραπεία οφθαλμικών παθήσεων που περιλαμβάνουν ένα αγγειακό παράγοντα, ιδίως γλαυκωματώδεις νευροπάθειες, εκφυλιστικές χοριο-αμφιβληστροειδοπάθειες του ισχυρού μύωπα, κηλιδώδεις εκφυλισμοί συνδεόμενοι με την ηλικία, βαριές κεντρικές χοριο-αμφιβληστροειδοπάθειες, κληρονομικές δυστροφίες του αμφιβληστροειδούς και φλεβικές εγκλείσεις του αμφιβληστροειδούς. Προκαλεί πρακτικώς πάντοτε μια βελτίωση της οπτικής λειτουργίας (οπτική οξύτητα και πεδίο).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TN99122 | 1999-06-16 | ||
FR9915359A FR2794975A1 (fr) | 1999-06-16 | 1999-12-06 | Medicaments opthalmologiques neuro et retino-protecteurs |
EP00951603A EP1185255B1 (fr) | 1999-06-16 | 2000-06-16 | MEDICAMENTS OPHTALMOLOGIQUES RETINO-PROTECTEURS comprenant du ramipril ou du ramiprilat |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110476T1 true CY1110476T1 (el) | 2015-04-29 |
Family
ID=21618071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100622T CY1110476T1 (el) | 1999-06-16 | 2009-06-11 | Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατη |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20020087834A (el) |
CY (1) | CY1110476T1 (el) |
FR (1) | FR2794975A1 (el) |
PT (1) | PT1185255E (el) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0114333B1 (en) * | 1982-12-27 | 1990-08-29 | Schering Corporation | Pharmaceutical composition |
DE3410732A1 (de) * | 1984-03-23 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Methode zur behandlung des glaukoms |
US4656188A (en) * | 1985-10-09 | 1987-04-07 | Merck & Co., Inc. | Ace inhibitors in macular degeneration |
JPH05306296A (ja) * | 1992-04-24 | 1993-11-19 | Marino Forum 21 | 魚類由来ペプチドとその製法 |
WO1999036062A1 (en) * | 1998-01-16 | 1999-07-22 | Alcon Laboratories, Inc. | Topical administration of angiotensin-converting enzyme inhibitors |
-
1999
- 1999-12-06 FR FR9915359A patent/FR2794975A1/fr not_active Withdrawn
-
2000
- 2000-06-16 KR KR1020017015972A patent/KR20020087834A/ko not_active Application Discontinuation
- 2000-06-16 PT PT00951603T patent/PT1185255E/pt unknown
-
2009
- 2009-06-11 CY CY20091100622T patent/CY1110476T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR20020087834A (ko) | 2002-11-23 |
PT1185255E (pt) | 2009-06-03 |
FR2794975A1 (fr) | 2000-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0001818A2 (hu) | A szem első kamrájában alkalmazható szabályzott felszabadulású gyógyszerhatóanyagok | |
WO2004028570A3 (en) | A method for treating severe tinnitus | |
DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
EP0998925A4 (en) | TOPICAL ADMINISTRATION COMPOSITIONS CONTAINING VITAMINS D AND VITAMINS K | |
EP1842567A3 (en) | Intraluminal device with a coating containing a therapeutic agent | |
HUP0401568A2 (hu) | Periokuláris vagy subconjunctivális adagolásra alkalmas szemészeti depó készítmények | |
AU766216C (en) | Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia | |
WO2004002999A3 (en) | Modified 2' and 3' -nucleoside produgs for treating flaviridae infections | |
CA2440764A1 (en) | Combination of brimonidine and timolol for topical ophthalmic use | |
BR0013540A (pt) | Formulações farmacêuticas e seu uso na prevenção de acidente vascular cerebral, diabetes e/ou falha de coração congestiva | |
WO2000018316A3 (en) | Sustained release, and comfortable ophthalmic composition and method for ocular therapy | |
DE69930271T8 (de) | Medizinische zusammensetzungen zur behandlung von augenerkrankungen | |
BR0109747A (pt) | Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática | |
BR0209063A (pt) | Medicamentos e kits de uso medicinal | |
SE8304616D0 (sv) | Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering | |
WO1995016435A3 (en) | Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent | |
CY1110476T1 (el) | Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατη | |
CA2414586A1 (en) | Agent for therapeutic treatment of optic nerve diseases and the like | |
DK1185255T3 (da) | Retinaprotektive oftalmologiske lægemidler indeholdende ramipril eller ramiprilat | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
AU2001223953A1 (en) | Use of l-carnitine as stabilizing agent of proteins | |
WO2001028578A3 (en) | A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME | |
Goldberg | Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J. Glaucoma 2001; 10: 414-22 | |
HUP0000716A2 (hu) | Fekélyes kolitisz és/vagy Crohn-féle betegség megelőzésére és kezelésére alkalmas gyógyszerkészítmény | |
Master | Study: Laser therapy more effective at 2 years than triamcinolone for DME patients |